Tislelizumab

About

Thing
Tislelizumab is a humanized monoclonal antibody directed against PD-1. It prevents PD-1 from binding to the ligands PD-L1 and PD-L2. It is being investigated as a treatment for advanced solid tumors. It is designed to bind less to Fc gamma receptors. It is being developed by BeiGene and Celgene Corp.
Tislelizumab
Definition
Tislelizumab is a humanized monoclonal antibody directed against PD-1. It prevents PD-1 from binding to the ligands PD-L1 and PD-L2. It is being investigated as a treatment for advanced solid tumors. It is designed to bind less to Fc gamma receptors. It is being developed by BeiGene and Celgene Corp.
Tislelizumab
Tislelizumab
Tislelizumab is a humanized monoclonal antibody directed against PD-1. It prevents PD-1 from binding to the ligands PD-L1 and PD-L2. It is being investigated as a treatment for advanced solid tumors. It is designed to bind less to Fc gamma receptors. It is being developed by BeiGene and Celgene Corp.

See also

See also: